Effect of eicosapentaenoic acid ethyl on urine albumin excretion in NIDDM.
Shimizu
H
H
Sato
N
N
Tanaka
Y
Y
Kashima
K
K
Ohtani
K
K
Mori
M
M
D000419:Albuminuria / Q000188:drug therapy*; D002214:Capsules; D003924:Diabetes Mellitus, Type 2 / Q000652:urine*; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D002214:Capsules; D010975:Platelet Aggregation Inhibitors; C035276:eicosapentaenoic acid ethyl ester; D015118:Eicosapentaenoic Acid